Verified Nov 2026
Other
·

Mumbai, Maharashtra
·
Since 1983
Sun Pharma, headquartered in Mumbai and founded in 1983, is India's pharmaceutical company with 41,000–100,000 employees and estimated annual revenue of $5–10 billion. The company manufactures specialty medicines, branded generics, active pharmaceutical ingredients, and over-the-counter products across dermatology, ophthalmology, and oncology. It operates manufacturing facilities in multiple countries and agreed in April 2026 to acquire US drugmaker Organon for $11.75 billion.
SUN Pharma at a glance
Revenue
$5-10B
Est. band
Employees
50,000-100,000
Founded
1983
Headquarters
Mumbai, Maharashtra
Import activity
15
Industries
Automotive
Electric Vehicles
Medical
Industrial Equipment
Sourcing and import activity
From US customs bill-of-lading records
US sea imports
15
Named foreign suppliers
2
Top origins
India · Morocco · Spain · The Bahamas

Shared foreign counterparties do not establish that these companies buy from SUN Pharma.
What this tells a buyer
The company shipped 3,624 units from India and also sources from Morocco, Spain, and The Bahamas; it signed a US government drug-pricing agreement in September 2026.
Sun Pharma develops technically complex formulations, active pharmaceutical ingredients, and specialty pharmaceuticals across multiple therapeutic areas with advanced drug delivery capabilities.
The company is recognized as the world's specialty generic pharmaceutical company operating in over 100 countries with an R&D investment rate of 7–8% of annual revenue.
Source: US customs bill-of-lading records and public filings · Last verified Nov 13, 2026
STABILITY SIGNALS
Established & active
43 years in operation (founded 1983).
15 US import shipments on record.
Overview
Sun Pharma, headquartered in Mumbai and founded in 1983, is India's pharmaceutical company with 41,000–100,000 employees and estimated annual revenue of $5–10 billion. The company manufactures specialty medicines, branded generics, active pharmaceutical ingredients, and over-the-counter products across dermatology, ophthalmology, and oncology. It operates manufacturing facilities in multiple countries and agreed in April 2026 to acquire US drugmaker Organon for $11.75 billion.
At a glance
Attribute | Detail |
|---|---|
Founded | 1983 |
Headquarters | Mumbai, Maharashtra |
Employees | 50,000-100,000 |
Revenue | $5-10B (estimated) |
What SUN Pharma makes
Sun Pharma develops technically complex formulations, active pharmaceutical ingredients, and specialty pharmaceuticals across multiple therapeutic areas with advanced drug delivery capabilities.
Trade and customs footprint
The company shipped 3,624 units from India and also sources from Morocco, Spain, and The Bahamas; it signed a US government drug-pricing agreement in September 2026. US customs bill-of-lading records list 15 inbound shipments across 2 foreign suppliers, with top origins including India · Morocco · Spain · The Bahamas.
Latest developments
2026-09-01 — Sun Pharma signs deal with US government to reduce drug prices | Company Business News (livemint.com)
2026-06-20 — Sun Pharma to Buy 100% Stake in Innovcare Lifesciences in ₹271 Crore Deal (sahi.com)
2026-06-19 — News Release (brampton.ca)
2026-04-27 — Sun Pharma to buy US drugmaker Organon for $11.75 billion in India's largest pharma deal (streetinsider.com)
2026-02-05 — Sun Pharma to pump in ₹500 cr in Assam to set up manufacturing unit - The HinduBusinessLine (thehindubusinessline.com)
2025-12-03 — Sun Pharma to set up ₹3000 cr manufacturing facility in MP, ETPharma (indiatimes.com)
Company details
The company is recognized as the world's specialty generic pharmaceutical company operating in over 100 countries with an R&D investment rate of 7–8% of annual revenue. SUN Pharma was founded in 1983, has an estimated 50,000-100,000 employees, and is headquartered in Mumbai, Maharashtra. On the LightSource stability read it is rated "Established & active": 43 years in operation (founded 1983). 15 US import shipments on record.
Frequently asked questions
What does SUN Pharma do?
Sun Pharma, headquartered in Mumbai and founded in 1983, is India's pharmaceutical company with 41,000–100,000 employees and estimated annual revenue of $5–10 billion. The company manufactures specialty medicines, branded generics, active pharmaceutical ingredients, and over-the-counter products across dermatology, ophthalmology, and oncology. It operates manufacturing facilities in multiple countries and agreed in April 2026 to acquire US drugmaker Organon for $11.75 billion.
Where is SUN Pharma headquartered?
SUN Pharma is headquartered in Mumbai, Maharashtra.
When was SUN Pharma founded?
SUN Pharma was founded in 1983.
How big is SUN Pharma?
SUN Pharma has an estimated 50,000-100,000 employees, with revenue in the $5-10B range (estimated).
Does SUN Pharma import from overseas suppliers?
US customs bill-of-lading records show 15 inbound shipments for SUN Pharma, with top origins including India · Morocco · Spain · The Bahamas.
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.
